Cardiovascular risk factors characteristic for the metabolic syndrome in adult patients with type 1 diabetes

Experimental and Clinical Endocrinology and Diabetes

Volumn 117, Issue 3, 2009, Pages 107-112

  Nadas J ^a   Putz, Z ^a   Fovenyi J ^b   Gaal Z ^c   Gyimesi, A ^d   Hidvegi T ^e   Hosszufalusi N ^f   Neuwirth, G ^g   Oroszlan T ^h   Panczel P ^f   Szeles G ⁱ   Vandorfi G ^j   Winkler, G ^k   Wittmann, I ^l   Jermendy, G ^a  

^a BAJCSY ZSILINSZKY HOSPITAL   (Hungary)

^b Peterfy Hospital   (Hungary)

^c Jósa András Hospital I   (Hungary)

^d Rethy Pal Hospital   (Hungary)

^e Petz Hospital   (Hungary)

^f SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^g Department of Neurology   (Hungary)

^h Department of Orthopaedics   (Hungary)

ⁱ UNIVERSITY OF DEBRECEN   (Hungary)

^j Cholnoky Ferenc Hospital   (Hungary)

^k ST JOHN'S HOSPITAL   (Hungary)

^l UNIVERSITY OF PÉCS   (Hungary)

more..

Author keywords

Abdominal obesity; Cardiovascular risk factor; Metabolic syndrome; Type 1 diabetes; Waist circumference

Indexed keywords

ANTIHYPERTENSIVE AGENT; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR RISK; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HUNGARY; INSULIN DEPENDENT DIABETES MELLITUS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADOLESCENT; ADULT; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS;

EID: 62749192556     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0028-1082088     Document Type: Article

References (30)

1. Alberti KGMM, Zimmet P, Shaw J. The metabolic syndrome - a new worldwide definition. Lancet 2005; 366: 1059-1062
2. Bonora E. The metabolic syndrome and cardiovascular disease. Ann Med 2006; 38: 64-80
3. Cockcroft D, Gault MD. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41
4. Davis TM, Bruce DG, Davis WA. Prevalence and prognostic implications of the metabolic syndrome in community-based patients with type 1 diabetes: the Fremantle Diabetes Study. Diabetes Res Clin Pract 2007; 78: 412-417
5. DeFronzo RA, Hendler R, Simonson D. Insulin resistance is a prominent feature of insulin-dependent diabetes. Diabetes 1982; 31: 795-801
6. Després JP. Intra-abdominal obesity: an untreated risk factor for Type 2 diabetes and cardiovascular disease. J Endocrinol Invest 2006; 29: 77-82
7. Després JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006; 444: 881-887
8. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497
9. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005; 28: 1769-1778
10. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-359
11. Ford ES, Li C. Physical activity or fitness and the metabolic syndrome. Expert Rev Cardiovasc Ther 2006; 4: 897-915
12. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502
13. Jermendy Gy, Hetyési K, Bíró L et al. Prevalence of the metabolic syndrome in hypertensive and/or obese subjects. Diabetic Med 2004; 21: 805-806
14. Kahn R, Buse J, Ferrannini E et al. The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2005; 48: 1684-1699
15. Kilpatrick ES, Rigby AS, Atkin SL. Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: "double diabetes" in the Diabetes Control and Complications Trial. Diabetes Care 2007; 30: 707-712
16. Lakka HM, Laaksonen DE, Lakka TA et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-2716
17. Lorenzo C, Williams K, Hunt KJ et al. The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care 2007; 30: 8-13
18. Maison P, Byrne CD, Hales CN et al. Do different dimensions of the metabolic syndrome change together over time? Evidence supporting obesity as the central feature. Diabetes Care 2001; 24: 1758-1763
19. Metascreen Writing Committee. The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes. Results form Metascreen, a multicenter diabetes clinic-based survey. Diabetes Care 2006; 29: 2701-2707
20. Nádas J, Putz Zs, Jermendy Gy et al. Public awareness of the metabolic syndrome. Diab Res Clin Pract 2007; 76: 155-156
21. Pambianco G, Costacou T, Orchard TJ. The prediction of major outcomes of type 1 diabetes: a 12-year prospective evaluation of three separate definitions of the metabolic syndrome and their components and estimated glucose disposal rate: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes Care 2007; 30: 1248-1254
22. Reaven GM. The role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607
23. Reindel J, Zander E, Heinke P et al. The metabolic syndrome in patients with type 1 diabetes mellitus: Associations with cardiovascular risk factors and cardiovascular morbidity. Herz 2004; 29: 463-469
24. Smith SC JR, Haslam D. Abdominal obesity, waist circumference and cardio-metabolic risk: awareness among primary care physicians, the general population and patients at risk - the Shape of the Nation survey. Curr Med Res Opin 2007; 23: 29-47
25. Széles G, Szigethy E, Vokó Z et al. The epidemiology of metabolic syndrome in the Hungarian adult population: a representative survey (abstract). Diabetes Care 2007; 56 (Suppl 1): A626
26. Teupe B, Bergis K. Epidemiological evidence for "double diabetes". Lancet 1991; 337: 361-362
27. The DCCT Research Group. Weight gain associated with intensive therapy in the Diabetes Control and Complications Trial. Diabetes Care 1988; 11: 567-573
28. Thorn LM, Forsblom C, Fagerudd J et al. Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care 2005; 28: 2019-2024
29. Vargane HP, Adany R. Trends of premature mortality from cardiovascular diseases in Hungary and the European Union, 1970-1997. Orv Hetil 2000; 141: 601-607
30. Yusuf S, Hawken S, Ounpuu S et al. Obesity and the risk of myocardial infarction in 27.000 participants from 52 countries: a case-control study. Lancet 2005; 366: 1640-1649